Amazentis Patents - Urolithin A (Mitopure)

Our proprietary Urolithin A - Mitopure® - is protected under the following patents in these territories:

United States

US 9,872,850

US 10,028,932

US 10,485,782

US 9,962,366

US 9,994,542

US 10,532,992

US 10,442,784

US 9,394,269

US 9,573,922

US 2017/0143666

US 2016/0213643

US 2018/0303794

US 2014/0018415

US 2018/0015069

US 2019/0263772

US 2018/0256538

US 2018/0256539

US 2018/0243261

US 2020/0140405

US 2018/0256471

US 2019/0008883

US 2019/0328703

Canada

CA 2,972,013

CA 2,822,898

CA 2,877,718

Europe

EP 2654461 B1

EP 3278800 B1

EP 3087065 B1

Israel

IL 227071

IL 252951

Russia

RU 2,606,763

Japan

JP 6,054,301

JP 6,254,667

JP 6,539,331

JP 6,422,163

JP 2019-187426

JP 2018-184455

Australia

AU 2011348068

AU 2016210622

AU 2018204108

AU 2018200791

AU 2018202407

P.R. China

CN ZL201180067142.4

CN ZL201380044735.8

CN 105497014

CN 110934863

Indonesia

ID IDP000050200

Rep. of Korea (“South Korea”)

KR 10-1955001

KR 10-1955004

KR 10-2072612

Philippines

PH 1-2020-500169

PH 1-2013-501333

South Africa

ZA 2013/05545

Knowledge is power
Sign up to our newsletter

Shop

InstagramFacebookYouTube

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. References: *Nutrition studies: 500mg Mitopure® have been shown to (1) induce gene expression related to mitochondria function and metabolism and (2) increase the strength of the hamstring leg muscle in measures of knee extension and flexion in overweight 40-65 year olds. Data from two randomized double-blind placebo-controlled human clinical trials. **Nutrition NOURISH Study: 500mg Mitopure® have been shown to deliver at least 6 times higher Urolithin A plasma levels over 24 hours (area under the curve) than 8 ounces (240ml) of pomegranate juice in a randomized human clinical trial.